Onconetix, Inc. Increase (Decrease) in Prepaid Expense
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Prepaid Expense of $7.75 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-03-13
- Onconetix, Inc. increase (decrease) in prepaid expense for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. increase (decrease) in prepaid expense for the quarter ending 2024-09-30 was $0.00.
- Onconetix, Inc. increase (decrease) in prepaid expense for the quarter ending 2024-06-30 was -$1.00, a 100.00% decline year-over-year.
- Onconetix, Inc. increase (decrease) in prepaid expense for the quarter ending 2024-03-31 was $7.75K.
- Onconetix, Inc. increase (decrease) in prepaid expense for fiscal 2024 was $7.75K, a 54.10% decline from fiscal 2023.
- Onconetix, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $16.88K, a 56.28% decline from fiscal 2022.
- Onconetix, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $38.62K.
- Onconetix, Inc. increase (decrease) in prepaid expense for fiscal 2021 was -$184.93K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | -$1.00 derived: sum of 3 quarters · filed 2026-03-13 | $7.75K 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.00 derived: sum of 2 quarters · filed 2025-11-13 | $7.75K 10-Q · filed 2025-11-13 | $7.75K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $7.75K 10-Q · filed 2025-08-14 | $7.75K derived: sum of 3 quarters · filed 2025-08-14 | $7.75K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $7.75K 10-Q · filed 2025-06-12 | $7.75K derived: sum of 2 quarters · filed 2025-06-12 | $7.75K derived: sum of 3 quarters · filed 2025-06-12 | $47.75K derived: sum of 4 quarters · filed 2025-06-12 | |||
| 2023-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $1.00 derived: sum of 2 quarters · filed 2025-06-02 | $40.00K derived: sum of 3 quarters · filed 2025-06-02 | $16.88K 10-K · filed 2025-06-02 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $40.00K derived: sum of 2 quarters · filed 2023-11-17 | $16.88K 10-Q · filed 2023-11-17 | -$10.86K derived: sum of 4 quarters · filed 2023-11-17 | |||
| 2023-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $16.88K 10-Q · filed 2023-10-20 | -$10.86K derived: sum of 3 quarters · filed 2023-10-20 | -$18.48K derived: sum of 4 quarters · filed 2023-11-17 | |||
| 2023-03-31 | -$23.12K 10-Q · filed 2023-05-12 | -$50.86K derived: sum of 2 quarters · filed 2023-05-12 | -$58.47K derived: sum of 3 quarters · filed 2023-11-17 | -$113.95K derived: sum of 4 quarters · filed 2023-11-17 | |||
| 2022-12-31 | -$27.74K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$35.36K derived: sum of 2 quarters · filed 2023-11-17 | -$90.84K derived: sum of 3 quarters · filed 2023-11-17 | $38.62K 10-K · filed 2023-03-09 | |||
| 2022-09-30 | -$7.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | -$63.10K derived: sum of 2 quarters · filed 2023-11-17 | $66.36K 10-Q · filed 2023-11-17 | $469.28K 10-Q · filed 2022-11-14 | -$136.84K derived: sum of 4 quarters · filed 2023-11-17 | ||
| 2022-06-30 | -$55.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $73.97K 10-Q · filed 2023-10-20 | $778.45K 10-Q · filed 2022-08-15 | -$129.22K derived: sum of 3 quarters · filed 2023-10-20 | -$188.46K derived: sum of 4 quarters · filed 2023-10-20 | ||
| 2022-03-31 | $129.45K 10-Q · filed 2023-05-12 | -$144.55K 10-Q · filed 2022-05-13 | -$73.74K derived: sum of 2 quarters · filed 2023-05-12 | -$132.98K derived: sum of 3 quarters · filed 2023-05-12 | -$112.79K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$203.20K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$262.43K derived: sum of 2 quarters · filed 2023-03-09 | -$242.24K derived: sum of 3 quarters · filed 2023-03-09 | -$184.93K 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$59.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$39.05K derived: sum of 2 quarters · filed 2022-11-14 | $18.26K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $20.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $77.50K 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | $57.31K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |